West Australian Sleep Disorders Research Institute
Perth, Western Australia, 6009, Australia
NCT Number: NCT07400861
Pressure Match (The APAP Min-Max tool) is a software-based clinical decision-support tool, developed using a causal-inference modelling approach based on data from thousands of OSA patients. The model takes as inputs from patient variables (e.g., baseline AHI, gender, weight/BMI, mask interface type), and outputs recommended AutoSet minimum and maximum pressure settings (cmH₂O) tailored for that patient phenotype.
The intended clinical role of the Pressure Match tool is to assist the clinician's choice of AutoSet pressure range when initiating CPAP therapy, with the goal of reducing clinician time/effort in manual titration and follow-up adjustments without compromising safety, efficacy or patient satisfaction.
The purpose of this trial is to test Pressure Match in a clinical trial setting, to demonstrate non-inferiority against standard APAP settings.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Perth, Western Australia, 6009, Australia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CPAP where the settings are personalized to each patient, recommended by Pressure Match tool.
CPAP set up on default out-of-box clinical pressure settings.
Time frame: 3 months
The primary endpoint is comparison of the mean residual AHI of the active group compared with the control group, to demonstrate non-inferiority.
Apnea-Hypopnea Index (AHI) is defined as the number of obstructive apnea and hypopnea events per hour of sleep. Apneas are episodes of complete cessation of airflow, and hypopneas are episodes of partial reduction in airflow.
Residual AHI is the AHI calculated from device-recorded data via validated detection algorithms collected while the participant is receiving therapy with the study device. Residual AHI reflects the frequency of obstructive respiratory events that remain during treatment and is used to assess treatment effectiveness.
Contact information is provided by the study sponsor or research team.
ResMed
Industry
Trial of a New Software Tool for Personalized Minimum and Maximum Pressure Recommendations in New CPAP Users With OSA
Acronym: SMART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07730879
Apnea, Cardiovascular Diseases
Braga, Portugal
View Trial DetailsNCT07720219
Apnea, Dyssomnias
View Trial DetailsNCT07711678
Apnea, Dyssomnias
Beijing, Beijing Municipality, China
View Trial DetailsNCT07693101
Apnea, Dyssomnias
View Trial Details